Never miss a story

Get subscribed to our newsletter


×
A woman's blood is collected for testing of coronavirus antibodies in Hempstead, N.Y., April 14, 2020. Doctors are seeking to grow antibodies and them against COVID-19. VOA
By Steve Baragona

Doctors are seeking to grow some of the body’s most potent disease-fighting weapons in a test tube and deploy them against COVID-19.

The treatment, known as monoclonal antibody therapy, could serve as both a remedy for patients infected with the coronavirus that causes COVID-19 and a way to prevent infection in frontline health workers and other people at high risk.


At least six companies expect to be testing antibodies on COVID-19 patients this summer.

Monoclonal antibodies have proven to be powerful tools against ailments including cancer and rheumatoid arthritis. A new treatment against Ebola is under review at the U.S. Food and Drug Administration.

Follow NewsGram on LinkedIn to know what’s happening around the world.

Antibodies have advantages over conventional drugs that put them near the front of the pack of new therapies under development against COVID-19. For one, producing them is relatively fast, thanks to technology developed in the last 10 to 15 years.

“The whole process, from getting a blood sample to having antibodies ready for the clinic, was about three months,” said antibody sciences director Laura Walker at biotech company Adimab.

While safety testing is just beginning, Walker said antibody treatment is generally fairly safe.


Aubrey Dhanraj, a plasma donor, lies on reclining seat to give convalescent plasma for coronavirus treatment at a newly opened plasma donor center in Twickenham, southwest London, June 11, 2020. VOA

“Everybody makes antibodies naturally,” she noted.

And since they are based on a well-studied part of the body’s defenses, Walker added, “the odds that a monoclonal antibody will be effective is quite high.”

Antibodies are a key part of the immune system. They work by attaching themselves to an invading germ. In the case of viruses, this blocks the invader from entering a cell and causing an infection as per doctors.

Skipping the vaccine

Vaccines trigger the same response. But since there is no vaccine for COVID-19, “we’re skipping the vaccination step and we’re directly making these antibodies,” said Joe Jardine at IAVI, a nonprofit scientific research organization.

Most of the antibodies come from people who have recovered from COVID-19 infection. Their blood is full of them, which is why doctors are testing whether giving COVID-19 patients convalescent plasma — the liquid part of blood from recovered people — could treat or prevent infection.

But collecting enough plasma to treat large numbers of patients is labor intensive, and plasma must be screened for other diseases the donor may be carrying.

The blood of recovered patients is also full of the cells that produce antibodies. In recent years, technology has emerged that can sort through millions of these cells to find the ones that produce the most potent antibodies against an individual germ. These cells then form the basis of a manufacturing process to grow large quantities of antibodies.

Patients would receive the treatment by injection or intravenous drip.

So far, two companies have monoclonal antibody therapies undergoing clinical trials for hospitalized COVID-19 patients. At least four others are expected to begin testing this summer.

Antibodies also could be used to provide temporary, vaccine-like protection from infection by doctors.


Antibodies also could be used to provide temporary, vaccine-like protection from infection. Pixabay

“This would function as a stopgap” for health care workers or other vulnerable people while vaccines are being developed, Jardine said, or as prevention for older people who don’t respond as well to vaccines.

Protection would likely last about a month, possibly six if the antibodies were modified.

Not just one virus

Walker’s group has isolated several antibodies that block not only the coronavirus behind COVID-19 but also the one that caused the 2003 SARS outbreak and a related coronavirus found in bats.

Also Read: Smart Watches Don’t Have Defined Place in Heart Risk Assessment: Researchers

The COVID-19 virus is the third coronavirus in less than two decades to emerge from the wild and kill humans. Many more are circulating in bats and other animals. As people increasingly move into wildlife habitats, humans are coming into contact with a growing number of viruses.

“It’s almost certain we’re going to see something like this happen in the future,” Walker said. “What you want is not just an antibody that works against the current virus, but also against future, related viruses.”

She hopes to start clinical trials later this year. (VOA)


Popular

Photo by Briana Tozour on Unsplash

According to the World Health Organization, in 2020 itself, there were 2.3 million women diagnosed with breast cancer in the world.

Over the last one-and-a-half-year, people have been vocal about both mental and physical health in relationships. Even while miles away from one another, people kept checking on the health and well-being of their loved ones. However, one issue, i.e., breast cancer has been affecting women throughout the world, and it still needs much more focus and attention.

According to the World Health Organization, in 2020 itself, there were 2.3 million women diagnosed with breast cancer in the world. A report published by National Cancer Registry Programme (NCRP) estimates that breast cancer cases are likely to increase by nearly 20 per cent. Throughout the world, the tenth month of the year is recognized as the month of "Pink October" to raise awareness about breast cancer. The month should also be a celebration of encouraging the women in our lives to take the first step in this journey of staying in "Pink of Health". happen, an international dating app, conducted an in-app survey to understand how Indians discuss health issues like breast cancer with their partners. The survey gave a glimpse of whether health issues are impacting the life and relationships of singles.

41 per cent of users are not aware of examinations related to women's health


Forty-one per cent of users shared that they did not encourage the women in their life (mother, sister, friend, etc.) to go for checkups for issues related to health. Sixteen per cent of the respondents confessed that they did not remind women in their life to take examinations for their own health. It is important to note that regular self-examination is likely to detect breast lumps early. One in eight women will develop breast cancer in her lifetime. If it is detected in time, it will be cured in nine out of 10 cases.

Keep Reading Show less
VOA

Saudi Aramco engineers and journalists look at the Hawiyah Natural Gas Liquids Recovery Plant, June 28, 2021, in Hawiyah, in the Eastern Province of Saudi Arabia.

One of the world's largest oil producers, Saudi Arabia, announced Saturday it aims to reach "net zero" greenhouse gas emissions by 2060, joining more than 100 countries in a global effort to try and curb man-made climate change.

The announcement, made by Crown Prince Mohammed bin Salman in brief scripted remarks at the start of the kingdom's first-ever Saudi Green Initiative Forum, was timed to make a splash a little more than a week before the start of the global COP26 climate conference being held in Glasgow, Scotland.

Keep Reading Show less
VOA

Apple's App Store app is seen on a smartphone in Baltimore, March 19, 2018.

Apple has updated its App Store rules to allow developers to contact users directly about payments, a concession in a legal settlement with companies challenging its tightly controlled marketplace.

According to App Store rules updated Friday, developers can now contact consumers directly about alternate payment methods, bypassing Apple's commission of 15 or 30%.

Keep reading... Show less